Trastuzumab and dyspnoea Patient Reports February 11, 2012
Trastuzumab Side Effects Report #5749723-2
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Female patient, 36 years of age, weighting 127.9 lb, was diagnosed with cardiac failure, cardiotoxicity and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: cardiomyopathy
, dyspnoea. Trastuzumab dosage: 6 MG/KG (342 MG) Q 3W PR. Patient recovered.Trastuzumab Side Effects Report #5115303-5
Trastuzumab side effect was reported by a Physician from AUSTRALIA on Mar 14, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, chest pain
, diarrhoea, dyspnoea, pyrexia, staphylococcal infection
. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5128130-X
Trastuzumab side effect was reported by a Pharmacist from AUSTRALIA on Sept 21, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, central line infection, chest pain
, diarrhoea, dyspnoea, haemoglobin decreased, staphylococcal infection
, thrombosis, white blood cell count decreased. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE, MAXOLON. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #6071682-6
Trastuzumab side effect was reported by a Pharmacist from UNITED STATES on Feb 06, 2009. Female patient, 71 years of age, weighting 218.3 lb, was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, body temperature increased, chills, dyspnoea, heart rate increased, nausea
, respiratory rate increased. Trastuzumab dosage: 406 MC GIVEN OF 775 MG. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #4644940-7
Trastuzumab side effect was reported by a Physician from on Apr 06, 2005. Female patient, 58 years of age, weighting 220.5 lb, was diagnosed with breast cancer
, breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood pressure increased, cardiac arrest
, cardiac failure congestive, cardiotoxicity, catheter site pain, cough, dyspnoea, feeling abnormal. Trastuzumab dosage: 2 MG/KG 1 PER WEEK INTRAVENOUS. During the same period patient was treated with CAELYX, NAVELBINE, HYDROCHLOROTHIAZIDE, ATENOLOL, DIAZEPAM, CELEBREX, BENADRYL. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5520363-3
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Female patient, 41 years of age, was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: chills, dyspnoea, flushing, headache
. Trastuzumab dosage: unknown. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #4935830-0
Trastuzumab side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2006. Female patient, 38 years of age, weighting 233.9 lb, was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Trastuzumab dosage: 196 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, DOCETAXEL, FLUOROURACIL, CYCLOPHOSPHAMIDE, EPIRUBICIN, IMODIUM, MAALOX. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5033196-1
Trastuzumab side effect was reported by a Health Professional from UNITED STATES on June 19, 2006. Female patient, 38 years of age, weighting 233.9 lb, was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Trastuzumab dosage: 196 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, DOCETAXEL, FLUOROURACIL, CYCLOPHOSPHAMIDE, EPIRUBICIN, IMODIUM, MAALOX. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5934658-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Oct 16, 2008. Female patient was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Trastuzumab dosage: 8 MG/KG, SINGLE. Patient recovered.Trastuzumab Side Effects Report #5944090-3
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Female patient was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Trastuzumab dosage: 8 MG/KG, SINGLE. Patient recovered.Trastuzumab Side Effects Report #5501798-1
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 18, 2007. Female patient, 72 years of age, weighting 180.8 lb, was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
. Trastuzumab dosage: unknown. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #6051923-1
Trastuzumab side effect was reported by a Pharmacist from UNITED STATES on Jan 21, 2009. Female patient, 60 years of age, weighting 108.0 lb, was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dyspnoea, nausea
. Trastuzumab dosage: 100 MG X 1 IV. Patient recovered.
Trastuzumab and dyspnoea 